Page last updated: 2024-11-02

phenoxybenzamine and Chronic Disease

phenoxybenzamine has been researched along with Chronic Disease in 12 studies

Phenoxybenzamine: An alpha-adrenergic antagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator.

Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).

Research Excerpts

ExcerptRelevanceReference
"In a single-blind, placebo-controlled, cross-over study in 11 patients with chronic non-suppurative, culture-negative prostatitis, alpha-difluoromethylornithine (alpha DFMO) (18 g/day) was administered orally for 1 month."7.66alpha-Difluoromethylornithine (alpha DFMO) and phenoxybenzamine hydrochloride in the treatment of chronic non-suppurative prostatitis. ( Dunzendorfer, U, 1981)
"In a single-blind, placebo-controlled, cross-over study in 11 patients with chronic non-suppurative, culture-negative prostatitis, alpha-difluoromethylornithine (alpha DFMO) (18 g/day) was administered orally for 1 month."3.66alpha-Difluoromethylornithine (alpha DFMO) and phenoxybenzamine hydrochloride in the treatment of chronic non-suppurative prostatitis. ( Dunzendorfer, U, 1981)
"The effects of acute and chronic hypoxemia on norepinephrine-stimulated lipolysis were studied in dogs."1.26Norepinephrine-stimulated lipolysis in acute and chronic hypoxemia. ( Baum, D; Oyer, P, 1981)
"Phenoxybenzamine was found to be effective in reversing and preventing these contractions."1.25Chronic cerebral arterial spasm. The role of intracranial pressure. ( Farrar, JK, 1975)

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19908 (66.67)18.7374
1990's2 (16.67)18.2507
2000's2 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jain, S1
Sharma, R1
Dunzendorfer, U1
Baum, D1
Oyer, P1
Boucher, M1
Dubar, M1
Chapuy, E1
Chassaing, C1
Bunc, G1
Kovacic, S1
Strnad, S1
Boreham, PF1
Braithwaite, P1
Milewski, P1
Pearson, H1
Scott, MB1
Morrow, JW1
Harders, H1
Farrar, JK1
Williams, AJ1
Palmer, KR1
Kim, WK1
Koff, RS1
Loggie, JM1

Reviews

1 review available for phenoxybenzamine and Chronic Disease

ArticleYear
Hypertension in children and adolescents. II. Drug therapy.
    The Journal of pediatrics, 1969, Volume: 74, Issue:4

    Topics: Age Factors; Antihypertensive Agents; Blood Pressure Determination; Child; Chlorothiazide; Chronic D

1969

Trials

1 trial available for phenoxybenzamine and Chronic Disease

ArticleYear
Alpha-adrenergic blockers in prostatism.
    The British journal of surgery, 1977, Volume: 64, Issue:10

    Topics: Chronic Disease; Clinical Trials as Topic; Humans; Male; Phenoxybenzamine; Prostatic Hyperplasia; Ti

1977

Other Studies

10 other studies available for phenoxybenzamine and Chronic Disease

ArticleYear
Analgesia in phasic and tonic pain tests in a pharmacological model of autotomy.
    Indian journal of experimental biology, 2002, Volume: 40, Issue:11

    Topics: Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Amphetamine; Analgesia; Animals; Behavio

2002
alpha-Difluoromethylornithine (alpha DFMO) and phenoxybenzamine hydrochloride in the treatment of chronic non-suppurative prostatitis.
    Arzneimittel-Forschung, 1981, Volume: 31, Issue:2

    Topics: Adult; Blood Cell Count; Chronic Disease; Drug Therapy, Combination; Eflornithine; Humans; Male; Mid

1981
Norepinephrine-stimulated lipolysis in acute and chronic hypoxemia.
    The American journal of physiology, 1981, Volume: 241, Issue:1

    Topics: Acute Disease; Animals; Chronic Disease; Dogs; Fatty Acids, Nonesterified; Glycerol; Hypoxia; Lipid

1981
Interactions of the cardiac chronotropic effects of rilmenidine with the autonomic nervous system in conscious dogs: comparison with clonidine.
    Journal of autonomic pharmacology, 1996, Volume: 16, Issue:1

    Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Atropine; Blood Pressure; Chronic Dis

1996
The effect of sympathetic nervous system exclusion on cerebral vasospasm following subarachnoid hemorrhage in rabbits.
    Acta neurochirurgica. Supplement, 2001, Volume: 77

    Topics: Adrenergic alpha-Antagonists; Animals; Basilar Artery; Chronic Disease; Ganglia, Sympathetic; Phenox

2001
Phenoxybenzamine in neurogenic bladder dysfunction after spinal cord injury. II. Autonomic dysreflexia.
    The Journal of urology, 1978, Volume: 119, Issue:4

    Topics: Autonomic Nervous System; Chronic Disease; Humans; Hypertension; Male; Nervous System Diseases; Phen

1978
[Chronic intestinal blood circulation disorders].
    Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 1976, Volume: 47, Issue:7

    Topics: Anticoagulants; Chronic Disease; Collateral Circulation; Glucagon; Heart Rate; Humans; Intestines; I

1976
Chronic cerebral arterial spasm. The role of intracranial pressure.
    Journal of neurosurgery, 1975, Volume: 43, Issue:4

    Topics: Animals; Cerebrovascular Circulation; Chronic Disease; Constriction, Pathologic; Epinephrine; Intrac

1975
Severe constipation as the presenting complaint of phaeochromocytoma.
    Australian and New Zealand journal of medicine, 1991, Volume: 21, Issue:6

    Topics: Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Atenolol; Chronic Disease; Constipation; Fe

1991
Coexistence of raynaud's phenomenon and chronic active hepatitis with hepatitis B antigen.
    Digestion, 1974, Volume: 11, Issue:1-2

    Topics: Adrenergic alpha-Antagonists; Adult; Autoantibodies; Biopsy; Chronic Disease; Hepatitis A; Hepatitis

1974